| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 05/06/2004 | US20040087507 Containing amino acid; long term storage stability |
| 05/06/2004 | US20040087502 Use of activated coagulation factor Vll for treating thrombolytic therapy-induced major bleedings |
| 05/06/2004 | US20040087486 Inhibiting vascular occlusive events; reducing circulating count below normal levels without serious adverse consequence |
| 05/06/2004 | US20040087035 Using myeloproliferative leukemic inhibitory agents to treatment and/ or prevention platelet related thrombotic and vaso-occlusive disorder |
| 05/06/2004 | US20040086942 Comprises peptide mimetic which competes for binding site of immunoglobulin receptor and prevents and treats allergic disorders |
| 05/06/2004 | US20040086877 Multi-mode directi memory access controller and method |
| 05/06/2004 | US20040086522 Strategies to prevent autoimmune disease by vaccination with vaccines based upon Epstein-Barr virus |
| 05/06/2004 | US20040086485 Viral vector sequences in plasmid form delivered in-vivo to generate vector producing cells |
| 05/06/2004 | EP1415994A1 Retinal pigmented epithelium derived neurotrophic factor |
| 05/06/2004 | EP1415993A1 Clopidogrel salts with alkyl-sulphuric acids |
| 05/06/2004 | EP1415992A1 Diamine derivatives |
| 05/06/2004 | EP1415990A1 Diazepan derivatives useful as factor X inhibitor |
| 05/06/2004 | EP1415983A1 5-amidino-n-(2-aminophenethyl)-hydroxybenzenesulfonamide derivative, medicinal composition containing the same, and intermediate therefor |
| 05/06/2004 | EP1415669A1 Process for sterilization of protein containing biological compositions |
| 05/06/2004 | EP1415659A1 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 05/06/2004 | EP1415650A1 Nutritional composition for the prevention and treatment of cachexia and anorexia |
| 05/06/2004 | EP1414866A2 Fgf-affinity chromatography |
| 05/06/2004 | EP1414855A2 Peptide inhibiting platelet derived growth factor (pdgf-bb) and fibroblast growth factor (bfgf) activity |
| 05/06/2004 | EP1414837A1 Adenosine a3 receptor agonists |
| 05/06/2004 | EP1414817A1 Substituted isoindoles and e use thereof |
| 05/06/2004 | EP1414810A2 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 05/06/2004 | EP1414790A1 Substituted n-acyl aniline derivatives, production and use thereof as medicaments |
| 05/06/2004 | EP1414788A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists |
| 05/06/2004 | EP1414522A2 Carbonic anhydrase inhibitors |
| 05/06/2004 | EP1414486A2 Use of glp-2 in combination with another therapeutic agent in bone-related and nutrition-related disorders |
| 05/06/2004 | EP1414480A1 Osteogenic growth oligopeptides as stimulants of hematopoiesis |
| 05/06/2004 | EP1414479A1 Peptide for regulation of tissue plasminogen activator |
| 05/06/2004 | EP1414456A1 Phenyl derivatives as factor xa inhibitors |
| 05/06/2004 | EP1414455A1 Isoquinoline inhibitors of p38 |
| 05/06/2004 | EP1414449A2 Bicyclic inhibitors of factor xa |
| 05/06/2004 | EP1414444A1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 05/06/2004 | EP1414443A1 BENZIMIDAZO 4,5-f]ISOQUINOLINONE DERIVATIVES |
| 05/06/2004 | EP1414440A1 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 05/06/2004 | EP1414316A1 Nutritional composition preventing bacterial overgrowth |
| 05/06/2004 | EP1268407B1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 05/06/2004 | EP1257548B1 Benzofuran carboxamides and their therapeutic use |
| 05/06/2004 | EP1036072B1 Thrombin receptor antagonists |
| 05/06/2004 | EP1000033B1 Heterocyclic derivatives which inhibit factor xa |
| 05/06/2004 | CA2502932A1 Triazole compounds for the treatment of dysmenorrhoea |
| 05/05/2004 | CN1494590A Modified thrombopoietin with reduced immunogenicity |
| 05/05/2004 | CN1494551A Modified granulocyte macrophage colony stimulating factor (GM-CSF) with reduced immunogenicity |
| 05/05/2004 | CN1494542A 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
| 05/05/2004 | CN1494541A Heterocyclic inhibitors of ERK 2 and uses thereof |
| 05/05/2004 | CN1494450A Manual processing systems and methods for providing blood components conditioned for pathogen inactivation |
| 05/05/2004 | CN1494435A Preparation for prophylaxis of restenosis |
| 05/05/2004 | CN1494433A Use of CD 23 antagonists for treatment of neoplastic disorders |
| 05/05/2004 | CN1494425A Carboxamide derivatives as therapeutic agents |
| 05/05/2004 | CN1494423A Benzimidazole derivatives as therapeutic agents |
| 05/05/2004 | CN1493357A Application of levant cotton in medicine |
| 05/05/2004 | CN1493345A Medicine composition for treating hematopiesis and its use |
| 05/05/2004 | CN1493290A Ferulaic acid piperazine drip pill and its preparation method |
| 05/05/2004 | CN1493281A Coumarin acetate drip pill and its preparation method |
| 05/05/2004 | CN1493276A Ferulaic acid sodium drip pill and its preparation method |
| 05/05/2004 | CN1148447C Amino-terminally trancated RANTES as chemokine antagonists |
| 05/05/2004 | CN1148353C Phosphatidase A2 inhibitor and its prepn process and use |
| 05/05/2004 | CN1148346C Hydrazine derivs. |
| 05/05/2004 | CN1148228C Gene medicine for treating hemophilia B and its preparing process |
| 05/05/2004 | CN1148206C Method for preparing fresh rehmannia root preparation |
| 05/05/2004 | CN1148179C 20-Hete antagonists and agonists |
| 05/04/2004 | US6730783 Reacting aminoguanidine with carbonyl compound to form amidinohydrazone; reduction; reacting with alkoxyamine; guanidinylation; anticoagulants |
| 05/04/2004 | US6730695 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for V1b and V1a arginine-vasopressin receptors |
| 05/04/2004 | US6730689 Heterocyclic amides such as n-(4-(2-(((methyl)amino)methyl)-1h-imidazol-1-yl)-2-fluorophenyl)-1-(3-amino-1,2-benzisoxazol-5-yl)-3-(trifluoromethyl)-1h-pyrazole-5-carboxamide, used as anticoagulants; prophylaxis of cardiovascular disorders |
| 05/04/2004 | US6730672 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents |
| 05/04/2004 | US6730660 Peritoneal dialysis solutions with polypeptides |
| 05/04/2004 | US6730504 Bacillus natto culture extract |
| 05/04/2004 | US6730328 Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity |
| 05/04/2004 | CA2296178C Human intestinal npt2b |
| 05/04/2004 | CA2183234C Agent for prophylaxis and treatment of thromboxane a2-mediated diseases |
| 04/29/2004 | WO2004035594A1 Intermediate for producing carboxypeptidase b inhibitor |
| 04/29/2004 | WO2004035588A1 Pyradazine compounds as gsk-3 inhibitors |
| 04/29/2004 | WO2004035579A1 Imidazopyridine derivative, process for producing the same, and use |
| 04/29/2004 | WO2004035132A2 Compositions and methods for inducing osteogenesis |
| 04/29/2004 | WO2004035081A1 Activity of osteogenic growth peptide (ogp) for promoting proliferation of hemopoietic progenitor cell in erythron and its use |
| 04/29/2004 | WO2004035066A1 Plasma preparation or serum preparation and process for producing the same |
| 04/29/2004 | WO2004035065A1 Hypoglycemic substances containing zinc |
| 04/29/2004 | WO2004034993A2 Methods of preventing morbidity and mortality by perioperative administration of a blood clotting inhibitor |
| 04/29/2004 | WO2004019868A3 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 04/29/2004 | WO2003104282A8 Glycoprotein vi - fc fusion protein for treating vascular disorders |
| 04/29/2004 | WO2003093242A3 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/29/2004 | WO2003086282A3 Nitric oxide donors, compositions and methods of use |
| 04/29/2004 | WO2003020949A3 Targeted nucleic acid constructs and uses related thereto |
| 04/29/2004 | WO2002102391A3 Composition comprising nanoparticulate spironolactone |
| 04/29/2004 | WO2002070669A3 Secreted proteins |
| 04/29/2004 | WO2001082953A8 Methods for treatment of diseases associated with inflammation under non-ischemic conditions |
| 04/29/2004 | US20040082798 Novel amino dicarboxylic acid derivatives with pharmaceutical properties |
| 04/29/2004 | US20040082796 Reacting a substituted benzonitrile with a cysteine compound |
| 04/29/2004 | US20040082790 Piperidine amides as modulators of chemokine receptor activity |
| 04/29/2004 | US20040082787 Chemical compounds |
| 04/29/2004 | US20040082786 Piperazine based inhibitors of factor xa |
| 04/29/2004 | US20040082765 Immobilization; sustained release |
| 04/29/2004 | US20040082658 Side-chain halogenated amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases |
| 04/29/2004 | US20040082631 Pyrazole compositions useful as inhibitors of ERK |
| 04/29/2004 | US20040082630 1g(a)-Amino-n-hydroxy-acetamide derivatives |
| 04/29/2004 | US20040082626 Cyclic compounds exhibiting thrombopoietin receptor agonism |
| 04/29/2004 | US20040082623 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists |
| 04/29/2004 | US20040082611 Novel sulfonyl derivatives |
| 04/29/2004 | US20040082602 Kinase inhibitor; analgesics; antiarthritic agents; antihistamines; gastrointestinal disorders |
| 04/29/2004 | US20040082596 Novel carbamate-substituted pyrazolopyridine derivatives |
| 04/29/2004 | US20040082593 Mixing with aqueous solution containing sulfuric acid or sodium bisulfate; stabilization |
| 04/29/2004 | US20040082589 Quinoline derivatives as nk-3 and nk-2 antagonists |